Home › Funds › Ceredex Value Advisors LLC › REGN

Ceredex Value Advisors LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Ceredex Value Advisors LLC reported holding 58,023 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$44.0M, representing 1.37% of its reported portfolio and ranking #8 among its reported holdings. Ceredex Value Advisors LLC has disclosed REGN holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)58.02K sh
Reported value held$44.00M
Portfolio Weight1.37%
First reportedQ1 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ceredex Value Advisors LLC's REGN position evolved

Ceredex Value Advisors LLC first disclosed a stake in REGN in Q1 2025 at 31,025 shares (US$19.7M). The position peaked in Q3 2026 at 58,023 shares, worth US$44.0M. Across 5 filings, Ceredex Value Advisors LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 58,023 shares valued at US$44.0M — a reduction of -11,347 shares quarter over quarter.. Notable position changes include a 114% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 31.02K $19.68M New
Q4 2025 28.55K $22.04M New
Q1 2026 32.45K $25.07M Add
Q2 2026 69.37K $43.25M Add
Q3 2026 58.02K $44.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Ceredex Value Advisors LLC held REGN?

Ceredex Value Advisors LLC has disclosed REGN holdings in 5 of the last 7 reported quarters, going back to Q1 2025.

What is Ceredex Value Advisors LLC's current position in REGN?

As of Q3 2026, Ceredex Value Advisors LLC holds 58.02K shares of REGN (REGENERON PHARMACEUTICALS), valued at $44.00M, representing 1.37% of its reported portfolio and ranking #8.

Has Ceredex Value Advisors LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Ceredex Value Advisors LLC reduced its position in REGN. The position peaked in Q3 2026 at 58.02K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.